Atenolol
Beta Blocking Agents, Selective
Sold as TENORMIN · MINT-ATENOL · AA-ATENIDONE
- Drug class
- Beta Blocking Agents, Selective
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 3
- Products on record
- 124
- FDA reports (12 mo)
- 2,507
Overview
Atenolol is an active pharmaceutical ingredient in the Beta Blocking Agents, Selective group (C07AB). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 71 | May 29, 2026 |
| CA Canada | Health Canada | 47 | May 29, 2026 |
| US United States | FDA | 6 | April 22, 2026 |
GBUnited Kingdom· MHRA
71 products
Uses
Atenolol oral solution is indicated for: • Management of hypertension • Management of angina • Management of cardiac arrhythmias • Myocardial infarction. Early intervention in the acute phase.
How to take
CACanada· Health Canada
47 products
Uses
APO-ATENOL (atenolol) is indicated for: • patients with mild or moderate hypertension. • the long-term management of patients with angina pectoris due to ischemic heart disease. Hypertension It is usually used in combination with other drugs, particularly a thiazide diuretic.
However, it may be tried alone as an initial agent in those patients in whom, in the judgement of the physician, treatment should be started with a beta-blocker rather than a diuretic. APO-ATENOL may be used in combination with diuretics and/or vasodilators to treat severe hypertension.
The combination of atenolol tablets with a diuretic or peripheral vasodilator has been found to be compatible. Limited experience with other antihypertensive agents has not shown evidence of incompatibility with atenolol. APO-ATENOL is not recommended for the emergency treatment of hypertensive crises.
3 Pediatrics). 4 Geriatrics)
USUnited States· FDA
6 products
Uses
INDICATIONS AND USAGE
Hypertension Atenolol tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.
These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including atenolol. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake.
Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
Drug interactions
Known interactions involving Atenolol. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 600. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL177360068 · revised June 25, 2021
- [2]Health Canada (DPD) · 00773689 · revised March 22, 2025
- [3]FDA DailyMed · 09b21985-1818-44… · revised November 26, 2024 [PDF]
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.